Search by Drug Name or NDC
NDC 62135-0191-22 Calcium Acetate 667 mg/1 Details
Calcium Acetate 667 mg/1
Calcium Acetate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC.. The primary component is CALCIUM ACETATE.
MedlinePlus Drug Summary
Calcium acetate is used to control high blood levels of phosphorus in people with kidney disease who are on dialysis (medical treatment to clean the blood when the kidneys are not working properly). Calcium acetate is in a class of medications called phosphate binders. It binds phosphorus that you get from foods in your diet and prevents it from being absorbed into your blood stream.
Related Packages: 62135-0191-22Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Calcium Acetate
Product Information
| NDC | 62135-0191 |
|---|---|
| Product ID | 62135-191_06d3e4e6-38bb-e690-e063-6294a90af4d1 |
| Associated GPIs | 52800020100120 |
| GCN Sequence Number | 048241 |
| GCN Sequence Number Description | calcium acetate CAPSULE 667 MG ORAL |
| HIC3 | C1A |
| HIC3 Description | ELECTROLYTE DEPLETERS |
| GCN | 13675 |
| HICL Sequence Number | 004884 |
| HICL Sequence Number Description | CALCIUM ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | Calcium Acetate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Calcium Acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 667 |
| Active Ingredient Units | mg/1 |
| Substance Name | CALCIUM ACETATE |
| Labeler Name | Chartwell RX, LLC. |
| Pharmaceutical Class | Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091312 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0191-22 (62135019122)
| NDC Package Code | 62135-191-22 |
|---|---|
| Billing NDC | 62135019122 |
| Package | 200 CAPSULE in 1 BOTTLE (62135-191-22) |
| Marketing Start Date | 2018-06-29 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.19506 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CALCIUM ACETATE 667 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis